Author

Fu FH

Professor of Biomedical Polymers, Soochow University - Cited by 20,387 - Biomaterials - Polymersomes - Drug Delivery - Targeted Cancer Therapy

Biography

Fu Fh  is a Research Professor at the School of Engineering Science of the University of Science and Technology of China (USTC), Hefei, China. He had great skills and successful article writing skills.
Title
Cited by
Year
Actively targeted nanomedicines for precision cancer therapy: Concept, construction, challenges and clinical translation
W Gu, F Meng, R Haag, Z ZhongJournal of controlled release 329, 676-695, 2021202
92
2021
Fluorinated α-helical polypeptides synchronize mucus permeation and cell penetration toward highly efficient pulmonary siRNA delivery against acute lung injury
C Ge, J Yang, S Duan, Y Liu, F Meng, L YinNano Letters 20 (3), 1738-1746, 2020202
89
2020
Transferrin-binding peptide functionalized polymersomes mediate targeted doxorubicin delivery to colorectal cancer in vivo
Y Wei, X Gu, Y Sun, F Meng, G Storm, Z ZhongJournal of controlled release 319, 407-415, 2020202
69
2020
Hybrid biodegradable nanomotors through compartmentalized synthesis
IAB Pijpers, S Cao, A Llopis-Lorente, J Zhu, S Song, RRM Joosten, ...Nano Letters 20 (6), 4472-4480, 2020202
55
2020
CD44‐specific A6 short peptide boosts targetability and anticancer efficacy of polymersomal epirubicin to orthotopic human multiple myeloma
W Gu, J An, H Meng, N Yu, Y Zhong, F Meng, Y Xu, JJLM Cornelissen, ...Advanced materials 31 (46), 19047, 2019201
42
2019
Low-toxicity transferrin-guided polymersomal doxorubicin for potent chemotherapy of orthotopic hepatocellular carcinoma in vivo
Y Wei, X Gu, L Cheng, F Meng, G Storm, Z ZhongActa biomaterialia 92, 196-204, 2019201
40
2019
CD44-targeted vesicles encapsulating granzyme B as artificial killer cells for potent inhibition of human multiple myeloma in mice
Y Zhong, F Meng, W Zhang, B Li, JCM van Hest, Z ZhongJournal of Controlled Release 320, 421-430, 2020202
35
2020
Emerging targeted drug delivery strategies toward ovarian cancer
Z Wang, F Meng, Z ZhongAdvanced Drug Delivery Reviews 178, 113969, 2021202
30
2021
Micellar paclitaxel boosts ICD and chemo-immunotherapy of metastatic triple negative breast cancer
X Qiu, Y Qu, B Guo, H Zheng, F Meng, Z ZhongJournal of Controlled Release 341, 498-510, 2022202
28
2022
Selective transferrin coating as a facile strategy to fabricate BBB-permeable and targeted vesicles for potent RNAi therapy of brain metastatic breast cancer in vivo
Y Wei, Y Sun, J Wei, X Qiu, F Meng, G Storm, Z ZhongJournal of controlled release 337, 521-529, 2021202
27
2021
GE11 peptide-installed chimaeric polymersomes tailor-made for high-efficiency EGFR-targeted protein therapy of orthotopic hepatocellular carcinoma
C Zhou, Y Xia, Y Wei, L Cheng, J Wei, B Guo, F Meng, S Cao, ...Acta biomaterialia 113, 512-521, 2020202
26
2020
Biodegradable polymersomes with structure inherent fluorescence and targeting capacity for enhanced photo‐dynamic therapy
S Cao, Y Xia, J Shao, B Guo, Y Dong, IAB Pijpers, Z Zhong, F Meng, ...Angewandte Chemie International Edition 60 (32), 17629-17637, 2021202
25
2021
Cyclic RGD-functionalized and disulfide-crosslinked iodine-rich polymersomes as a robust and smart theranostic agent for targeted CT imaging and chemotherapy of tumor
Y Zou, Y Wei, Y Sun, J Bao, F Yao, Z Li, F Meng, C Hu, G Storm, Z ZhongTheranostics 9 (26), 8061, 2019201
25
2019
Efficient and targeted drug/siRNA co-delivery mediated by reversibly crosslinked polymersomes toward anti-inflammatory treatment of ulcerative colitis (UC)
X Xu, W Yang, Q Liang, Y Shi, W Zhang, X Wang, F Meng, Z Zhong, L YinNano Research 12, 659-667, 2019201
23
2019
Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy
H Zheng, B Guo, X Qiu, Y Xia, Y Qu, L Cheng, F Meng, Z ZhongBioactive materials 16, 1-11, 222
20
2022
Daratumumab immunopolymersome‐enabled safe and CD38‐targeted chemotherapy and depletion of multiple myeloma
N Yu, Y Zhang, J Li, W Gu, S Yue, B Li, F Meng, H Sun, R Haag, J Yuan, ...Advanced Materials 33 (39), 07787, 212
20
2021
Immunotherapy of Malignant Glioma by Noninvasive Administration of TLR9 Agonist CpG Nano‐Immunoadjuvant
J Wei, D Wu, S Zhao, Y Shao, Y Xia, D Ni, X Qiu, J Zhang, J Chen, F Meng, ...Advanced Science 9 (13), 2103689, 2022202
19
2022
α3β1 Integrin-Targeting Polymersomal Docetaxel as an Advanced Nanotherapeutic for Nonsmall Cell Lung Cancer Treatment
Y Zou, Y Sun, B Guo, Y Wei, Y Xia, Z Huangfu, F Meng, JCM van Hest, ...ACS applied materials & interfaces 12 (13), 14905-14913, 2020202
18
2020
Systemic administration of polymersomal oncolytic peptide LTX-315 combining with CpG adjuvant and anti-PD-1 antibody boosts immunotherapy of melanoma
Y Xia, J Wei, S Zhao, B Guo, F Meng, B Klumperman, Z ZhongJournal of Controlled Release 336, 262-273, 2021202
16
2021
Apolipoprotein E peptide-guided disulfide-cross-linked micelles for targeted delivery of sorafenib to hepatocellular carcinoma
Y Li, J Wei, Y Wei, L Cheng, B Guo, F Meng, F Li, Z ZhongBiomacromolecules 21 (2), 7-724, 2019201
16
2019

Referred From: https://scholar.google.com/citations?user=iVawVMYAAAAJ&hl=en

Cited by
Citations 20387
h-index 73
i10-index 158
Recommended Journals
Open Access Journals